A moxonidine trial has been stopped by Lilly and Solvay because of a higher mortality rate | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.04.1999 | News item

A moxonidine trial has been stopped by Lilly and Solvay because of a higher mortality rate

Erschienen in: Reactions Weekly | Ausgabe 1/1999

Einloggen, um Zugang zu erhalten

Anzeige

Titel: A moxonidine trial has been stopped by Lilly and Solvay because of a higher mortality rate
Publikationsdatum: 01.04.1999
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/1999
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-199907450-00004